Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative methods for developmental toxicity testing.

Aldert H Piersma1

  • 1Laboratory for Toxicology, Pathology and Genetics, National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, the Netherlands. ah.piersma@rivm.ml

Basic & Clinical Pharmacology & Toxicology
|April 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exposure matters: The impact of exposure characteristics on In Vitro neurotoxicity of pesticides and implications for regulatory testing.

Toxicology·2026
Same author

A pipeline for developing AI-driven models to predict molecular initiating events: a case study on neural tube defects.

Journal of cheminformatics·2026
Same author

Corrigendum to "Hypothesis-driven approach to developmental toxicity assessment: Using mechanistic information to inform testing" [Reprod. Toxicol. 140 (2026) 109119].

Reproductive toxicology (Elmsford, N.Y.)·2025
Same author

Hypothesis-driven approach to developmental toxicity assessment: Using mechanistic information to inform testing.

Reproductive toxicology (Elmsford, N.Y.)·2025
Same author

Mechanisms of developmental neurotoxicity mediated by perturbed thyroid hormone homeostasis in the brain: an adverse outcome pathway network.

Critical reviews in toxicology·2025
Same author

A computational dynamic systems model for <i>in silico</i> prediction of neural tube closure defects.

Current research in toxicology·2025
Same journal

Using Pharmacovigilance Data for Signal Detection of Drug Interactions for Rosuvastatin.

Basic & clinical pharmacology & toxicology·2026
Same journal

Identifying Current Needs in Paediatric Pharmacoepidemiology: Insights From the NorPEN 2025 Workshop.

Basic & clinical pharmacology & toxicology·2026
Same journal

Contribution of Countries and International Collaboration in Clinical Pharmacology Research. A Cross-Sectional Bibliometric Study of Six Top Ranked Specialty Society Journals.

Basic & clinical pharmacology & toxicology·2026
Same journal

Pharmacological Inhibition of Cav2.2 Channels by Recombinant Phα1β Toxin (CTK01512-2).

Basic & clinical pharmacology & toxicology·2026
Same journal

Medication Burden: Beyond Counts to Recognize Polypharmacy as an Inherent Part of Living With Chronic Kidney Disease.

Basic & clinical pharmacology & toxicology·2026
Same journal

Modulation of Respiratory Diseases by the Endocannabinoid System: A Therapeutic Perspective.

Basic & clinical pharmacology & toxicology·2026
See all related articles

Researchers are developing alternatives to animal testing in developmental toxicology to reduce animal use and improve safety testing. Genomics and gene expression studies show promise for future in vitro testing strategies.

Area of Science:

  • Developmental toxicology
  • In vitro testing
  • Genomics

Background:

  • Three decades of research focused on alternatives to animal testing in developmental toxicology.
  • Aims include reducing animal use, refining assessments, and accelerating safety testing.
  • Many alternatives developed, utilizing biological materials from cell lines to embryos.

Purpose of the Study:

  • To review the progress and current state of alternatives in developmental toxicology.
  • To highlight emerging technologies like genomics for in vitro testing.
  • To discuss the potential of gene expression studies in future testing strategies.

Main Methods:

  • Review of existing research and developed alternatives.
  • Exploration of genomics and gene expression analysis.

Related Experiment Videos

  • Assessment of validation and application of alternatives in testing strategies.

    • Main Results:

    • Significant progress made in developing alternatives, though validation and application are in early stages.
    • Genomics technology offers a promising avenue for in vitro developmental toxicity testing.
    • Gene expression studies present unique insights into embryonic and fetal development.

    Conclusions:

    • Alternatives to animal testing in developmental toxicology are advancing.
    • Genomics and gene expression studies are poised to significantly enhance in vitro testing strategies.
    • Further development and validation are needed for widespread application of these alternatives.